About Event
The 8th Tumor Models San Francisco Summit 2024
The Tumor Models San Francisco Summit was the only West Coast industry-led meeting dedicated to defining preclinical modelling approaches, with real-world case studies to support oncology studies that empowered people to accelerate your candidate’s clinical translatability with optimized efficiency, and cost-effectiveness.
With the FDA Modernization Act 2.0 enabling non-animal models to be integrated into drug pipelines and combination regimes gaining approval as targeted therapies, the humanized animal model space is projected to boom to $338 million by 2027. Alongside this growth and the current high rate of attrition in oncology, the need for more clarity on best practice in tumor modelling also increases to ensure you don’t fall behind.
The 8th annual event returned to San Francisco in January 2024 which provided an update on tumor model advancements, and how they can complement existing models to increase clinical confidence and clinical relevancy in your candidate.
About The 2024 Event
Drug Developers and Academics – Attendance is Free: We are here to support your translational study and pipeline progression, and offer you the opportunity to meet model providers to select the right platforms and hence, drug developers and researchers are eligible for complimentary passes
Gain in-depth case studies into mouse models and newer models: Delve into strategies to accurately recapitulate tumor heterogeneity and tumor microenvironment from PDX, GEMMs to organoid models
Networking: You will have the unique opportunity to exchange challenges, inspire solutions with leading industry experts across dedicated speed-networking sessions as well as assess the latest technologies over the last 12 months
Novel Topics: Deep dive into brand-new case studies on leveraging tumor models to assess different modalities from ADCs, cell therapies, RNA therapeutics and more through to leveraging spatial technologies to enhance your data readouts
Form meaningful partnerships: Meet and network with selected CROs, model developers and academics to hear their latest platforms that will optimize your workflows